SIGHINOLFI, GIAN LUCA
 Distribuzione geografica
Continente #
NA - Nord America 2.555
AS - Asia 1.196
EU - Europa 901
SA - Sud America 177
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 9
Totale 4.911
Nazione #
US - Stati Uniti d'America 2.447
SG - Singapore 429
CN - Cina 220
IT - Italia 168
GB - Regno Unito 154
HK - Hong Kong 147
FI - Finlandia 145
BR - Brasile 133
VN - Vietnam 121
SE - Svezia 115
DE - Germania 102
BD - Bangladesh 101
RU - Federazione Russa 55
CA - Canada 52
FR - Francia 43
IN - India 38
MX - Messico 27
KR - Corea 26
ID - Indonesia 20
AR - Argentina 19
ZA - Sudafrica 19
PL - Polonia 15
IQ - Iraq 13
BG - Bulgaria 12
UA - Ucraina 11
LT - Lituania 10
MY - Malesia 10
SI - Slovenia 10
AT - Austria 9
JP - Giappone 9
PK - Pakistan 9
UZ - Uzbekistan 9
AU - Australia 8
DK - Danimarca 8
ES - Italia 8
MA - Marocco 8
NL - Olanda 8
TR - Turchia 8
BE - Belgio 7
CO - Colombia 7
CR - Costa Rica 6
KE - Kenya 6
PH - Filippine 6
CL - Cile 5
IR - Iran 5
VE - Venezuela 5
IL - Israele 4
JO - Giordania 4
NI - Nicaragua 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
BY - Bielorussia 3
EC - Ecuador 3
GP - Guadalupe 3
GT - Guatemala 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
JM - Giamaica 2
NP - Nepal 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TW - Taiwan 1
ZM - Zambia 1
Totale 4.885
Città #
Ashburn 400
Singapore 295
Santa Clara 236
Chandler 169
Hong Kong 146
San Jose 145
Fairfield 141
Helsinki 127
Council Bluffs 103
Nyköping 76
Houston 63
London 62
Seattle 54
Woodbridge 53
Los Angeles 52
The Dalles 45
Southend 39
New York 38
Beijing 37
Munich 37
Wilmington 37
Cambridge 36
Chicago 32
Ho Chi Minh City 32
Hefei 27
Modena 26
Seoul 26
Hanoi 25
San Diego 22
Dallas 20
Princeton 18
Shanghai 18
Bremen 17
Lauterbourg 17
Turku 17
Ann Arbor 16
Jakarta 16
Johannesburg 16
Milan 16
Brooklyn 15
Fremont 15
Phoenix 15
Atlanta 14
Da Nang 14
Jacksonville 14
São Paulo 13
Toronto 13
Buffalo 12
Portsmouth 12
Sofia 12
Denver 11
Montreal 11
Moscow 11
Orem 11
Warsaw 11
Chennai 9
Dearborn 9
Mexico City 9
Parma 9
Baghdad 8
Genoa 8
Mumbai 8
Ottawa 8
Rome 8
Frankfurt am Main 7
Nuremberg 7
Salt Lake City 7
Stockholm 7
Sydney 7
Tokyo 7
Boston 6
Nairobi 6
Poplar 6
Redondo Beach 6
Rio de Janeiro 6
Saint Augustine 6
San José 6
Tashkent 6
Amsterdam 5
Manchester 5
Newark 5
Padua 5
San Francisco 5
Amman 4
Birmingham 4
Biên Hòa 4
Boardman 4
Bologna 4
Changsha 4
Charlotte 4
Clifton 4
Columbus 4
Dhaka 4
Dong Ket 4
Düsseldorf 4
Ghent 4
Haiphong 4
Louisville 4
Managua 4
Miami 4
Totale 3.215
Nome #
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 447
Carcinogenic potential of metal nanoparticles in BALB/3T3 cell transformation assay. 391
A Machine Learning Approach to Predict Weight Change in ART-Experienced People Living with HIV 311
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 302
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 299
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 296
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 290
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 285
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 263
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 249
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 243
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 230
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 220
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 207
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 207
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 206
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 179
Conflicting interpretations of the prevalence of mutations associated with drug resistance in antiviral naïve HIV-1 patients with acute and chronic infection 177
Tossicità in vitro di nanoparticelle metalliche in linee e colture cellulari neuronali 109
Totale 4.911
Categoria #
all - tutte 22.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.097


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022216 0 0 0 5 13 12 8 13 42 12 51 60
2022/2023475 69 67 36 41 58 50 14 52 41 0 19 28
2023/2024281 8 16 24 36 53 34 25 32 4 10 15 24
2024/2025917 25 10 13 79 149 139 84 41 129 43 66 139
2025/20262.017 133 74 127 232 336 166 273 83 170 194 139 90
2026/2027477 41 124 102 210 0 0 0 0 0 0 0 0
Totale 4.911